Table 1.
Demographic and clinical characteristics.a
Beforeb |
After 2ndc |
After 3rdd |
|||||||
---|---|---|---|---|---|---|---|---|---|
Samples | Age (years) |
Gender | Blood group | HLA | HBcAb (S/CO) |
HBsAg (IU/ml) |
HBsAb (mIU/ml) |
HBsAb (mIU/ml) |
HBsAb (mIU/ml) |
1 | 22 | Male | B type | DRB1*140601 DRB1*150201 DQB1*030101 DQB1*060101 DPB1*040201 DPB1*090101 |
0 | 0 | 0 | 0.5 | 75.3 |
2 | 22 | Male | A type | DRB1*1101 DRB1*040501 DQB1*030101 DQB1*040101 DPB1*020102 DPB1*0501 |
0 | 0 | 0 | 9.6 | 391.3 |
3 | 24 | Male | B type | DRB1*090102 DRB1*150201 DQB1*030302 DQB1*060101 DPB1*0501 DPB1*090101 |
0 | 0 | 0 | 0.7 | 431.1 |
4 | 24 | Male | O type | DRB1*080302 DRB1*090102 DQB1*030302 DQB1*060101 DPB1*020102 DPB1*0501 |
0 | 0 | 0 | 11.2 | 632.6 |
5 | 25 | Male | O type | DRB1*040301 DRB1*100101 DQB1*030302 DQB1*050101 DPB1*020102 DPB1* |
0 | 0 | 0 | 3.4 | 619.3 |
a All five participants were Asian, had no HB immunization history, were in overall good health, and did not taking any regular medication during the study.
b Before HB vaccination.
c After the second HB vaccination.
d After the third HB vaccination.